PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isovaleramide | 208-781-1 | 541-46-8 | - | - | - | - | 1 | - | - | - | - | Details |
| 1,3-dichlorobenzene | 208-792-1 | 541-73-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 5-methylheptan-3-one | 208-793-7 | 541-85-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Chloroacetic anhydride | 208-794-2 | 541-88-8 | - | - | - | - | 1 | - | - | - | - | Details |
| 3-methylcyclopentadecan-1-one | 208-795-8 | 541-91-3 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 6-methyl-1,3,5-triazine-2,4-diyldiamine | 208-796-3 | 542-02-9 | - | - | 1 | - | - | - | - | - | - | Details |
| δ-valerolactone | 208-807-1 | 542-28-9 | - | - | 1 | - | - | - | - | - | - | Details |
| Dibutyl carbonate | 208-816-0 | 542-52-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Cyclopentadiene | 208-835-4 | 542-92-7 | - | - | - | - | 1 | - | - | - | - | Details |
| N-acetylglycine | 208-839-6 | 543-24-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Diisopentyl ether | 208-857-4 | 544-01-4 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Calcium diformate | 208-863-7 | 544-17-2 | - | - | 1 | - | - | - | - | - | - | Details |
| Ethyl linoleate | 208-868-4 | 544-35-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Batilol | 208-874-7 | 544-62-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Hexadecane | 208-878-9 | 544-76-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Trizinc dicitrate | 208-901-2 | 546-46-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Octaphenylcyclotetrasiloxane | 208-904-9 | 546-56-5 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Lithium acetate | 208-914-3 | 546-89-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Magnesium carbonate | 208-915-9 | 546-93-0 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Methyl isobutyrate | 208-929-5 | 547-63-7 | - | - | - | - | 1 | - | - | - | - | Details |
| [4-[4,4'-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride | 208-953-6 | 548-62-9 | - | - | - | - | - | - | 1 | - | - | Details |
| Benzene-1,2,4-tricarboxylic acid 1,2-anhydride | 209-008-0 | 552-30-7 | - | - | 2 | - | 2 | - | 1 | 1 | - | Details |
| Lithium salicylate | 209-011-7 | 552-38-5 | - | - | - | - | 1 | - | - | - | - | Details |
| α-chloro-o-xylene | 209-013-8 | 552-45-4 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-nitrobenzaldehyde | 209-025-3 | 552-89-6 | - | - | - | - | 1 | - | - | - | - | Details |